Kitov Announces License Agreement for KIT-302 in South Korea
Kitov Pharmaceuticals Holdings Ltd., an innovative biopharmaceutical company, announced today that the Company has signed a definitive License Agreement for its lead product candidate,…
Read More...
Read More...
